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I. Introduction 
1,3-B1s (2carboxycromon 5-yloxy)-2-hydroxypro- 
pane disodium salt (disodium cromoglycate, DSCG) 
is a widely used drug in the prophylaxis and treat- 
ment of IgE-dependent bronchial asthma [I ,2]. Accu- 
1nulated evidence indicates that DSCG inhibits the 
liberation of the mediators of immediate type allergic 
reactionsinitiated by reaginic antibody-antigen inter- 
action. It is not an antagonist of histamine. brady- 
kinin, or the slow-reacting substance of anaphylaxis 
(SRS-A), nor is it anti-inflammatory [3]. It doeshow- 
ever inhibit the degranulation of mast cells and the 
mediators release in response to various immunologic 
and non-immunologic stimuli [4-61 and prevents 
homologous passive cutaneous anaphylactic (PCA) 
reactions in the rat [7,8]. Both histamine release from 
isolated rat mast cells, and its inhibition by DSCG 
were found to be calcium dependent [9,10]. Further- 
more, it has been shown that DSCG produces a dose- 
related inhibition of antigen-stimulated 45Ca2+ uptake 
by mast cells [ 1 I]. Therefore the suggestion was 
made that DSCG interferes with the calcium trans- 
port across the mast cell menlbrane thereby inhibiting 
the anaphylactic release of mediators [ 121. Mg*+ were 
found to competitively suppress the effect of calcium 
[13], whereas the heavier alkaline earth ions, stron- 
tium and barium, were both found to be effective in 
the activation of anaphylactic histamine release yet 
at higher concentrations than those required with 
Ca’+ [ 131. Since the structure of the cromoglycate 
molecule contains carboxylate, ketonic, aromatic and 
aliphatic ether groups properly spaced [14] it should 
be capable of chelating alkaline earth and transition 
metal ions. This observation taken together with the 
above-mentioned role of this drug in affecting Ca2+ 
influx and histamine secretion from mast cells 
prompted us to investigate the direct binding of 
cromoglycate to alkaline earth and transition metal 
ions. We have indeed found that cromoglycate binds 
alkaline earth ions in aqueous and methanolic solu- 
tions. In the latter solvent the following affinities 
were determined by monitoring the fluorescence of 
the cromoglycate’ Mg2’. 1 X IO4 M-l; Ca*‘, 1 X 10’ 
M-‘;Sr’+, 3 X 10’ M-‘;Ba*‘. 1.8 X lo6 M-l. The 
stoichiometry of all complexes is 1: 1. The binding 
characteristics have also been confirmed by NMR 
measurements. which suggest hat the metal ions are 
coordinated to the two carboxylates of one cromo- 
glycate molecule. This type of chelate leaves several 
coordination sites on the metal available for inter- 
action with the target site on the mast cell. Thus the 
drug might putatively act by forming a specific ter- 
nary complex with alkaline earth ions and the Ca2* 
gate on the cell membrane, blocking the influx of 
these ions induced upon antigen binding to the IgE 
antibodies on the cell. 
2. Materials and methods 
DSCG was a kind gift of Fisons Pharmaceut. 
All chemicals were of analytical grade and were 
used without further purification. Fluorescence 
spectra of cromoglycate and its complexes were 
measured at saturation of the cromoglycate 
(1 .O X lo-’ M methanolic solutions) with the res- 
pective alkaline earth salt (5.0 X 10e3 M). Spectra 
were recorded in the ratio mode on a Perkin-Elmer 
MPF 44A spectrofluorometer in a thermostated 
quartz cuvette (7 X 7 mm) at 25°C excited at 
326 f 1 mm. The li, values of cromoglycate with 
various alkaline earth and transition metal ions were 
determined by automatic continuous fluorometric 
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titrations of a 1 X 1 0e5 M methanolic DSCG solution 
with a concentrated methanolic solution of the alka- 
line earth salt (5 X 1 0e3 M) on a Perkin-Elmer MPF- 
44A spectrofluorometer operated in the ratio mode. 
The intrinsic fluorescence of cromoglycate (emitted 
at 450 f 5 nm and excited at 326 + 1 nm) was 
enhanced upon binding the metal ions. The titrant 
was added continuously from a motor-driven Hamilton 
syringe to the thermostated quartz cuvette 
(7 X 7 mm) containing the mechanically stirred cro- 
moglycate solution. The fluorescence analog signal 
was digitized by a transient recorder (Biomation 802, 
Cupertino, CA.). A minimization computer program 
based on the Powell algorithm [16] was then applied 
to the experimental data of the saturation curve. 
NMR measurements of DSCG in CDaOD and in 
(CD3)2S0 were performed at room temperature on a 
Bruker 270 MHz spectrometer. 
3. Results and discussion 
The interactions between the metal ions and cro- 
moglycate were monitored via the intrinsic fluores- 
cence and NMR of the ligand. The ultraviolet spec- 
trum of DSCG in water shows maxima at 320 nm and 
260nmwithelll 1.0X lo4 and 1.8X IO4 
(M-’ . cm-‘), respectively. The emission intensity of 
an aqueous solution of the DSCG salt is quite low 
(quantum yield: @I = 0.004) but when dissolved in 
methanol it is enhanced -2-fold. Addition of Ca2+ 
(as the perchlorate salt), or the other alkaline earth 
ions, to the methanolic solutions of DSCG causes 
an enhancement of the emission which reaches a max. 
2-fold increase at saturation. The quantum yield of 
the Ca2+ complex is the largest 0.015, and those of 
Sr”, Ba2+ and Mg2+ complexes are lower (0.010, 
0.008,0.006, respectively). The fluorescence spectra 
of the complexes formed with the latter ions, all 
excited at 326 nm, are shown in fig.1. There is a blue 
shift of the emission maximum, relative to that of the 
sodium salt, which is correlated with the ionic radii 
of the binding metal ions, with Mg” being the excep- 
tion. The relative shifts can be seen in fig.1. A fluores- 
cence titration of DSCG with Ca2+ is shown in fig.2 
along with the resulting Scatchard plot. The stoichiom- 
etry of the Ca2+ complex is 1: 1, and the binding 
constant is 1 .O X 10’ M-’ (25°C). Similar titrations 
were also carried out with the other alkaline earth 
ions and with Zn2’ and Mn’+. The binding constants 
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Fig.1. Fluorescence spectra of cromoglycate complexes 
formed with alkaline earth ions at 25°C excited at 
326 + 1 nm. Insert: Excitation spectra of the same solutions 
(emission at 450 + 5 nm). 
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Fig.2. Fluorometric titration of DSCG with Ca(ClO,), in 
methanol at 25°C. The fluorescence analog signal was digi- 
tized by a transient recorder. A minimization computer pro- 
gram based on the Powell algorithm was then applied to the 
experimental data of the saturation curve (upper insert). The 
Scatchard plots are the result of the best fit parameters to the 
experimental data. Lower insert: Alinear correlation between 
the ionic radii of alkaline earth and transition metal ions and 
their affinity for cromoglycate (expressed as the log of their 
K, value). The numbers represent: 1, Mg*+; 2, Zn’+: 3. Mn*+; 
4, Cati. Sr2+.6 BaZ+. ,> ,, 
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for Mg’+, Sr*+, Ba”, Zn2+ and Mn” complexes are 
1 X 104M-‘,3X 105M-‘,1.8X 106M-‘, 
2.2 X lo4 M-‘, 4.7 X lo4 M-‘, respectively. The 
stoichiometry for all cases was also found to be 1: I 
The relatively low affinity for Mg2+ is noteworthy in 
view of its inhibitory effect on degranulation [ 131. 
NMR measurements of DSCG in (CD3)2S0, and 
in CDaOD show that upon binding of Ca’+, the pro- 
ton (no. 3) closest to the carboxy-groups undergoes a 
large downfield chemical shift (0.2 ppm). This could 
be explained by the cation bound causing a reduc- 
tion in the electron density at this locus. All the other 
protons on the ring (no. 668) are less affected 
(0.03 ppm). Thus, one may conclude that the groups 
chelating the Ca2+ are the two carboxylates. Further- 
more. the NMR spectrum demonstrates the identity 
of the protons on the two halves of the bound sym- 
metric ligand molecule. Since the complex is formed 
in a 1: 1 ratio, this implies a structure where both car- 
boxylates of one dicromoglycate molecule are bound 
to the calcium ion in a symmetrical way. 
The inhibition of antigen-induced mediator release 
from mast cells by cromoglycate has been suggested 
to be due to its interference with calcium transport 
across the cell membrane [l?,]. This still leaves one 
with the problem of resolving between interference 
occurring by a direct block of Ca’+ gates or indirectly 
by affecting the cellular level of CAMP [ 121. 
An attractive hypothesis for the mode of action of 
DSCG is that the Ca2’ influx is interfered with by a 
specific ternary complex formed by the cell mem- 
brane gate, a Ca2+ and the drug. This hypothesis gains 
some support from the above-reported affinity 
between the two latter components and we are 
presently investigating the binding of the complex 
between these two to the mast cell membranes. 
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